Search

everythinglearnresearchcommunity

for

Search:↓

AP-1 controls tumor cell type by affecting key signaling pathways.

Anabolic androgenic steroids can increase cancer risk and disrupt hormones.

Imaging intestinal stem cells might help detect early signs of colorectal cancer.

Albumin and prednisone improved symptoms in a woman with Cronkhite-Canada syndrome, revealing potential genetic causes.

Always consider xanthomatous hypophysitis before deciding on pituitary surgery.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Presurgical models can effectively and affordably screen cancer prevention agents.

Kawasaki Disease is rare and often missed in adults, who show different symptoms than children, and may benefit from early treatment.

Tislelizumab can cause cutaneous lupus erythematosus.

Erlotinib can cause excessive eyelash growth.

Metastatic cervical cancer can cause rare, severe Cushing's syndrome with high risk of death.

ACTH-dependent Cushing's syndrome linked to metastatic cervical cancer is rare and has high risks.

Low-penetration genes might help personalize colorectal cancer prevention.

Some prostate cancers have gene changes that may affect treatment with certain drugs.

TURP specimens should be checked for various tumors, not just common prostate issues.

Krt15+ cells in the mouse intestine resist radiation and can start tumors.

The report described a unique case of Cronkhite-Canada syndrome with unusual polyps and an association with multiple myeloma.

There is no standard treatment for the rare Cronkhite–Canada syndrome, which can be fatal and lead to cancer.

Adrenocortical carcinoma is a rare, aggressive adrenal gland cancer with a poor outlook.

Cronkhite-Canada syndrome is a rare condition causing gut polyps, hair loss, skin changes, and nail issues, often with a poor outlook.

Most adrenal cortex tumors are benign and non-secreting, but proper diagnosis and treatment are important due to the rare possibility of cancer.

Finasteride effectively reduces prostate size and symptoms in most BPH patients.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Inhibiting AP-1 changes skin tumor types and affects tumor cell identity.

Block and replace therapy improved symptoms in recurrent cyclic Cushing’s disease.

A rare adrenal tumor in a woman only made DHEA-S, causing hair thinning, and was removed, fixing the hormone level.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Chemoprevention can significantly lower cancer risks and needs more research and collaboration.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

The conclusion is that there might be a link between certain types of baldness and prostate cancer, which could be due to shared hormonal pathways.